Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
allogeneic human mesenchymal stem cells (Longeveron)
- Development stage
- Unknown
- Lead developer
- Longeveron
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
This investigational cell therapy consists of allogeneic human mesenchymal stem cells (hMSCs) derived from the umbilical cord. It is being evaluated by Dr. Bernard (Barry) Baumel at the University of Miami for the treatment of mild to moderate Alzheimer's disease. The therapy involves the intravenous infusion of approximately 100 million cells per dose, typically administered in a series of four infusions. The mechanism of action is believed to be multifactorial, involving immunomodulatory, anti-inflammatory, and neuroprotective properties that target neuroinflammation, cerebrovascular dysfunction, and neurodegeneration. As an academic investigational product, it does not currently have a commercial brand name.
- Other names
- umbilical cord-derived allogeneic human mesenchymal stem cellshMSC
Beyond the preview
Go deeper on allogeneic human mesenchymal stem cells (Longeveron).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on allogeneic human mesenchymal stem cells (Longeveron).